Oklo’s 270% Surge Raises $12B Valuation Despite Pre-Revenue Status
Oklo's shares have surged 270% YTD, lifting its market cap to $12 billion despite zero revenue and no NRC-approved reactors. Its fast-spectrum Aurora design can produce 75 MWe with a 14 GW backlog, yet the stock trades at 10× book value and 750× projected 2027 sales.
1. Overvalued Market Valuation
Oklo’s market capitalization has surged from approximately $17 billion at the start of the year to nearly $25 billion at its October peak, reflecting a more than 270% share price increase. Despite having no revenue, the company trades at roughly ten times book value—five times the average multiple in the energy sector—and at around 750 times its projected 2027 sales of $16 million. By comparison, a peer with an approved small modular reactor design trades at sixteen times its 2027 revenue estimates, highlighting the premium investors are currently assigning to Oklo’s future growth potential.
2. Advanced Reactor Technology and Partnerships
Oklo’s flagship Aurora fast-spectrum reactor is designed to generate up to 75 megawatts of electricity—enough to power a mid-size data center—using high-assay low-enriched uranium (HALEU) fuel that can operate for ten years without refueling. Modular and scalable, these powerhouses are targeted not only at hyperscale data centers but also at remote military bases, mining sites and research facilities. The company has already announced partnerships with data center operators to pilot its reactors and has secured a backlog totalling 14 gigawatts of potential future installations.
3. Cash Runway and Regulatory Timeline
With $1.2 billion in cash and equivalents on hand, Oklo projects sufficient liquidity to fund development through final licensing and demonstration phases. The company is currently navigating the Nuclear Regulatory Commission’s approval process and does not expect commercial revenue until 2027 or 2028. Given the typical multi-year review cycle for advanced reactor designs, any delays in regulatory sign-off could extend the pathway to cash flow, increasing execution risk despite the substantial cash buffer.